ANTIESTROGENS IN TREATMENT OF BREAST-CANCER

被引：90

作者：

LEGHA, SS

CARTER, SK

机构：

[1] NCI, DIV CANC TREATMENT, INVEST DRUG BRANCH, PROGRAM CANC THERAPY EVAL, BETHESDA, MD 20014 USA

[2] NO CALIF CANC PROGRAM, PALO ALTO, CA 94304 USA

来源：

CANCER TREATMENT REVIEWS | 1976年 / 3卷 / 04期

关键词：

D O I：

10.1016/S0305-7372(76)80010-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：205 / 216

页数：12

共 63 条

[1] ANTI-ESTROGENS AND PLASMA-PROTEINS .1. CLOMIPHENE AND ISOMERS, ETHAMOXYTRIPHETOL, U-11,100A AND U-11,555A [J].

BARBOSA, J ;

SEAL, US ;

DOE, RP .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 36 (04) :666-678

[2]

BLOOM HJG, 1967, CANCER-AM CANCER SOC, V20, P2118, DOI 10.1002/1097-0142(196712)20:12<2118::AID-CNCR2820201209>3.0.CO

[3]

2-U

[4] ANTIESTROGENS IN TREATMENT OF BREAST-CANCER - VALUE OF NAFOXIDINE IN 52 ADVANCED CASES [J].

BLOOM, HJG ;

BOESEN, E .

BRITISH MEDICAL JOURNAL, 1974, 2 (5909) :7-10

[5]

BREWIN TB, 1973, 8 INT C CHEM ATH

[6]

BREWIN TB, 1972, JUN S INT THER NONM

[7] PERSISTENCE OF URINARY OESTROGEN EXCRETION AFTER OOPHORECTOMY AND ADRENALECTOMY [J].

BULBROOK, RD ;

GREENWOOD, FC .

BRITISH MEDICAL JOURNAL, 1957, 1 (MAR23) :662-666

[8]

CALLANTINE MERRITT R., 1967, CLIN OBSTET GYNECOL, V10, P74, DOI 10.1097/00003081-196703000-00007

[9]

CARTER AC, 1976, COMMUNICATION

[10] ESTROGEN RECEPTORS AND ANTAGONISM OF STEROID-HORMONE ACTION [J].

CLARK, JH ;

PECK, EJ ;

ANDERSON, JN .

NATURE, 1974, 251 (5474) :446-448

← 1 2 3 4 5 6 7 →